Allele Capitals' Matt
Hughes will moderate future forward panel on enterprise need
in wearables for a variety of healthcare applications
PLEASANTON, Calif., June 28,
2024 /PRNewswire/ -- Movano
Health (Nasdaq: MOVE) announced the addition of two
expert participants to its B2B: The Next Wearables Boom
Virtual Event to be held on July 11 –
Dr. Fatima Rodriguez and
Matt Hughes.
Dr. Rodriguez and Mr. Hughes will join Movano Health CEO
John Mastrototaro and Movano Health
Chief Commercial Officer Michael
Soule for the event.
"We are thrilled to be able to discuss the exciting B2B
possibilities that our Evie enterprise solutions will open up with
such an accomplished group of experts," said Movano CEO
John Mastrototaro. "It is an
exciting time for wearables in healthcare and I am looking forward
to providing all our attendees with a glimpse into the future we
are building."
Dr. Fatima Rodriguez is an
Associate Professor in Cardiovascular Medicine and the Section
Chief of Preventive Cardiology at Stanford
University. Dr. Rodriguez earned her medical degree
from Harvard Medical School and her MPH
from the Harvard School of Public
Health. She then completed internal medicine residency at
Brigham and Women's Hospital and fellowship in cardiovascular
medicine at Stanford University. Dr.
Rodriguez specializes in cardiovascular disease prevention,
inherited lipid disorders, and cardiovascular risk assessment in
high-risk populations. Her research focuses on the innovative use
of technology to improve cardiovascular disease prevention, patient
empowerment, and health equity.
Matt Hughes serves as Managing
Partner at Allele Capital. With 15 years of experience in the
financial industry, Matt previously led initiatives at Noble
Capital Markets focused on biotechnology and specialty
pharmaceuticals equity research sales, where he honed his
understanding of what drives the intersection of innovation and
markets. Matt received an M.S. in Biotechnology at Johns Hopkins University and also received a B.B.A
in Entrepreneurship and a B.A in Mathematics from Florida Atlantic University. Matt serves on
Wilmington Capital Securities' Life Sciences Investment Banking
Division. Matt is a Level II CAIA candidate and holds FINRA Series
7, 79, and 63 licenses.
Attendees can register for the event here.
About Movano Health
Founded in 2018, Movano
Inc. (Nasdaq: MOVE) dba Movano Health is developing a suite of
purpose-driven healthcare solutions to bring medical-grade data to
the forefront of wearables. Featuring modern and flexible form
factors, Movano Health's devices offer an innovative approach to
delivering trusted data to both customers and enterprises,
capturing a comprehensive picture of an individual's health data
and uniquely translating it into personalized and intelligent
insights.
Movano Health's proprietary technologies and wearable medical
device solutions will soon enable the use of data as a tool to
proactively monitor and manage health outcomes across a number of
patient populations that exist in healthcare. For more information
on Movano Health, visit https://movanohealth.com/.
Forward Looking Statements
This press release
contains forward-looking statements concerning our expectations,
anticipations, intentions, beliefs, or strategies regarding the
future. These forward-looking statements are based on assumptions
that we have made as of the date hereof and are subject to known
and unknown risks and uncertainties that could cause actual
results, conditions, and events to differ materially from those
anticipated. Therefore, you should not place undue reliance on
forward-looking statements. Examples of forward-looking statements
include, among others, statements we make regarding plans with
respect to the commercial launches of the Evie Ring and Evie Med;
planned cost-cutting initiatives; anticipated FDA clearance
decisions with respect to our products; expected future operating
results; product development and features, product releases,
clinical trials and regulatory initiatives; our strategies,
positioning and expectations for future events or performance.
Important factors that could cause actual results to differ
materially from those in the forward-looking statements are set
forth in our most recent Annual Report on Form 10-K and any
subsequent Quarterly Reports on Form 10-Q, and in our other reports
filed with the Securities and Exchange Commission, including under
the caption "Risk Factors." Any forward-looking statement in
this release speaks only as of the date of this release. We
undertake no obligation to publicly update any forward-looking
statement, whether written or oral, that may be made from time to
time, whether as a result of new information, future developments
or otherwise.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/movano-health-announces-dr-fatima-rodriguez-joining-july-11-virtual-event-302184745.html
SOURCE Movano